Literature DB >> 16639906

Individuals versus organisms versus populations in the definition of ecological assessment endpoints.

Glenn W Suter1, Susan B Norton, Anne Fairbrother.   

Abstract

Discussions and applications of the policies and practices of the U.S. Environmental Protection Agency (USEPA) in ecological risk assessment will benefit from continued clarification of the concepts of assessment endpoints and of levels of biological organization. First, assessment endpoint entities and attributes can be defined at different levels of organization. Hence, an organism-level attribute, such as growth or survival, can be applied collectively to a population-level entity such as the brook trout in a stream. Second, assessment endpoints for ecological risk assessment are often mistakenly described as "individual level," which leads to the idea that such assessments are intended to protect individuals. Finally, populations play a more important role in risk assessments than is generally recognized. Organism-level attributes are used primarily for population-level assessments. In addition, the USEPA and other agencies already are basing management decisions on population or community entities and attributes such as production of fisheries, abundance of migratory bird populations, and aquatic community composition.

Entities:  

Mesh:

Year:  2005        PMID: 16639906

Source DB:  PubMed          Journal:  Integr Environ Assess Manag        ISSN: 1551-3777            Impact factor:   2.992


  2 in total

1.  A Risk-Based Ecohydrological Approach to Assessing Environmental Flow Regimes.

Authors:  Glenn B Mcgregor; Jonathan C Marshall; Jaye S Lobegeiger; Dean Holloway; Norbert Menke; Julie Coysh
Journal:  Environ Manage       Date:  2017-03-27       Impact factor: 3.266

Review 2.  The pros and cons of ecological risk assessment based on data from different levels of biological organization.

Authors:  Jason R Rohr; Christopher J Salice; Roger M Nisbet
Journal:  Crit Rev Toxicol       Date:  2016-06-24       Impact factor: 6.184

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.